Metabolism reprogramming induced by 2DG makes the neuroblastoma RAS viral oncogene homolog (NRAS) mutant melanoma cells sensitive to BRAF inhibitor (BRAFi) sorafenib [24]. This evidence concerns the gene NRAS and melanoma.